January 29, 2015
The American Heart Association Scientific Sessions in November featured the presentation of several major studies with practice-changing implications for the field of cardiology. After the conference, Cardiology Today asked leading experts to share their thoughts and perspective on trials including IMPROVE-IT, DAPT, WOSCOPS and more.
Robert A. Harrington, MD, chair of the 2014 AHA Scientific Sessions Program Committee, said this conference provided attendees with scientific data and discussion around “broad areas of science, from bench discovery science, through clinical and translational research, through population health and implementation science. “We can read about the science as it comes out or we can follow along with social media and traditional media, but nothing replaces face-to-face as a way to have a conversation, ask a question or probe data,” Harrington, the Arthur L. Bloomfield professor of medicine and chair of the department of medicine at Stanford University, told Cardiology Today.